CTKB logo

Cytek Biosciences, Inc. Stock Price

NasdaqGS:CTKB Community·US$751.8m Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 9 Fair Values set on narratives written by author

CTKB Share Price Performance

US$5.88
-0.81 (-12.11%)
US$8.00
Fair Value
US$5.88
-0.81 (-12.11%)
26.5% undervalued intrinsic discount
US$8.00
Fair Value
Price US$5.88
AnalystHighTarget US$8.00
AnalystLowTarget US$4.00
AnalystConsensusTarget US$5.13

CTKB Community Narratives

AnalystHighTarget·
Fair Value US$8 26.5% undervalued intrinsic discount

Growing Global Healthcare Investment And AI Will Advance Cytometry Adoption

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AnalystLowTarget·
Fair Value US$4 47.0% overvalued intrinsic discount

Rising Costs And Trade Tensions Will Shrink Flow Cytometry Markets

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AnalystConsensusTarget·
Fair Value US$5.13 14.7% overvalued intrinsic discount

Cloud Software And Flow Cytometry Will Unlock Global Opportunity

0users have liked this narrative
0users have commented on this narrative
6users have followed this narrative
US$5.13
14.7% overvalued intrinsic discount
Revenue growth
6.74% p.a.
Profit Margin
14.21%
Future PE
22.76x
Share price in 2028
US$6.29

Updated Narratives

CTKB logo

Rising Costs And Trade Tensions Will Shrink Flow Cytometry Markets

Fair Value: US$4 47.0% overvalued intrinsic discount
0 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
CTKB logo

Growing Global Healthcare Investment And AI Will Advance Cytometry Adoption

Fair Value: US$8 26.5% undervalued intrinsic discount
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
CTKB logo

Cloud Software And Flow Cytometry Will Unlock Global Opportunity

Fair Value: US$5.13 14.7% overvalued intrinsic discount
6 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Excellent balance sheet and overvalued.

1 Risk
0 Rewards

Cytek Biosciences, Inc. Key Details

US$196.8m

Revenue

US$91.6m

Cost of Revenue

US$105.2m

Gross Profit

US$118.0m

Other Expenses

-US$12.8m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
-0.10
53.46%
-6.51%
2.2%
View Full Analysis

About CTKB

Founded
1992
Employees
692
CEO
Wenbin Jiang
WebsiteView website
cytekbio.com

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. The company offers aurora and northern lights systems delivers cell analysis; aurora cell sorter system that leverages full spectrum profiling technology to further broaden potential applications across cell analysis; enhanced small particle detection; amnis imagestream imaging flow cytometers; guava muse cell analyzers; guava easycyte flow cytometers; and orion reagent cocktail preparation systems. It also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments. In addition, the company offers automated micro-sampling system and automated sample loader system, an automated loaders designed to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. It serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. The company distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in Europe, Latin America, and the Middle East countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.

Recent CTKB News & Updates

Revenues Tell The Story For Cytek Biosciences, Inc. (NASDAQ:CTKB) As Its Stock Soars 43%

Nov 22
Revenues Tell The Story For Cytek Biosciences, Inc. (NASDAQ:CTKB) As Its Stock Soars 43%

Recent updates

No updates